"Benzyl Alcohols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Alcohols derived from the aryl radical (C6H5CH2-) and defined by C6H5CHOH. The concept includes derivatives with any substituents on the benzene ring.
| Descriptor ID |
D001592
|
| MeSH Number(s) |
D02.033.160 D02.455.426.559.389.140.200
|
| Concept/Terms |
Benzyl Alcohols- Benzyl Alcohols
- Alcohols, Benzyl
- Phenylmethanols
- Phenylcarbinols
|
Below are MeSH descriptors whose meaning is more general than "Benzyl Alcohols".
Below are MeSH descriptors whose meaning is more specific than "Benzyl Alcohols".
This graph shows the total number of publications written about "Benzyl Alcohols" by people in this website by year, and whether "Benzyl Alcohols" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2017 | 3 | 0 | 3 |
| 2018 | 3 | 2 | 5 |
| 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Benzyl Alcohols" by people in Profiles.
-
Comparative Anti-Inflammatory Effects of Salix Cortex Extracts and Acetylsalicylic Acid in SARS-CoV-2 Peptide and LPS-Activated Human In Vitro Systems. Int J Mol Sci. 2021 Jun 23; 22(13).
-
Toxicological Assessment of Intermediates in Natural Attenuation of p-Xylene to Marine Microalgae. Bull Environ Contam Toxicol. 2019 Sep; 103(3):441-446.
-
Kinetic analysis and degradation mechanism for natural attenuation of xylenes under simulated marine conditions. Ecotoxicol Environ Saf. 2019 Jan 30; 168:443-449.
-
The Efficacy and Safety of Once-daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-daily Budesonide/Formoterol in a Subgroup of Patients from China with Symptomatic COPD at Risk of Exacerbations (FULFIL Trial). COPD. 2018 Jun-Aug; 15(4):334-340.
-
Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting ß2-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trial. Respir Med. 2018 08; 141:111-120.
-
COPD 2017: A Year in Review. COPD. 2018 04; 15(2):118-122.
-
Glucocorticoid Receptor Nuclear Translocation in CD4 T Cells from Severe and Moderate Asthmatic Patients Treated with Fluticasone/Vilanterol. Iran J Allergy Asthma Immunol. 2018 Feb; 17(1):1-8.
-
Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease. Expert Rev Respir Med. 2017 12; 11(12):955-967.
-
Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi. Eur J Pharmacol. 2017 Oct 05; 812:147-154.
-
Could phase 3 medicine trials be tagged as pragmatic? A case study: The Salford COPD trial. J Eval Clin Pract. 2018 02; 24(1):258-261.